These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1391980

  • 1. Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients.
    Reid AD, Horobin JM, Newman EL, Preece PE.
    Breast Cancer Res Treat; 1992; 22(2):153-6. PubMed ID: 1391980
    [Abstract] [Full Text] [Related]

  • 2. Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses.
    Camaggi CM, Strocchi E, Canova N, Costanti B, Pannuti F.
    Cancer Chemother Pharmacol; 1985; 14(3):229-31. PubMed ID: 3158448
    [Abstract] [Full Text] [Related]

  • 3. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T, Patel JK, Rosner D, Dao TL, Halvorson H.
    J Surg Oncol; 1989 Aug; 41(4):226-9. PubMed ID: 2526907
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H, Senoo T, Nishiki M, Morimoto T, Takashima S.
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
    [Abstract] [Full Text] [Related]

  • 5. Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
    Gasparini G, Canobbio L, Galligioni E, Fassio T, Brema F, Crivellari D, Villalta D, Di Fronzo G, Talamini R, Monfardini S.
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1451-9. PubMed ID: 2960532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).
    Beex L, Rose C, Mouridsen H, Jassem J, Nooij M, Estape J, Paridaens R, Piccart M, Gorlia T, Lardenoije S, Baila L.
    Eur J Cancer; 2006 Dec; 42(18):3178-85. PubMed ID: 17045796
    [Abstract] [Full Text] [Related]

  • 9. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E, Jouve M, Palangie T, Bretaudeau B, Asselain B, Magdelenat H, Merle S, Zajdela A, Pouillart P.
    Bull Cancer; 1984 Dec; 71(1):22-9. PubMed ID: 6324934
    [Abstract] [Full Text] [Related]

  • 10. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ, Gebski V, Forbes J, Tattersall MH, Simes RJ, Coates AS, Dewar J, Lunn M, Flower C, Gill PG, Stewart J.
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [Abstract] [Full Text] [Related]

  • 11. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S, Yamamoto H, Inaii H, Koyama H.
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
    [Abstract] [Full Text] [Related]

  • 12. Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group.
    Japan Advanced Breast Cancer Study Group, Japan Clinical Oncology Group.
    Jpn J Cancer Res; 1993 Apr; 84(4):455-61. PubMed ID: 8514613
    [Abstract] [Full Text] [Related]

  • 13. Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.
    Hardy JR, Powles TJ, Judson IR, Sinnett HD, Ashley SE, Coombes RC, Ellin CL.
    Eur J Cancer; 1990 Apr; 26(7):824-7. PubMed ID: 2145904
    [Abstract] [Full Text] [Related]

  • 14. [Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications].
    Mauriac L, Durand M, Bonichon F, Chauvergne J.
    Bull Cancer; 1986 Apr; 73(2):148-54. PubMed ID: 2942203
    [Abstract] [Full Text] [Related]

  • 15. [Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].
    Palmeri R, Papalia E, Lazzara S, Belnome NA, Gorgone S, Calbo E, Melita P.
    Chir Ital; 1987 Apr; 39(2):185-92. PubMed ID: 2958166
    [Abstract] [Full Text] [Related]

  • 16. Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
    Bonte J, Janssens JP, Ide P.
    Eur J Gynaecol Oncol; 1986 Apr; 7(1):45-50. PubMed ID: 2938955
    [Abstract] [Full Text] [Related]

  • 17. Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.
    De Lena M, Tommasi S, Schittulli F, Lorusso V, Paradiso A.
    Tumori; 1990 Apr 30; 76(2):190-5. PubMed ID: 2139523
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Whitney CW, Brunetto VL, Zaino RJ, Lentz SS, Sorosky J, Armstrong DK, Lee RB, Gynecologic Oncology Group study.
    Gynecol Oncol; 2004 Jan 30; 92(1):4-9. PubMed ID: 14751130
    [Abstract] [Full Text] [Related]

  • 19. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
    Matsumoto S, Kutsuna T, Tann M, Mizuno Y, Shinohara M, Kimura T, Banno T, Yoshizaki S.
    Gan To Kagaku Ryoho; 1989 Jul 30; 16(7):2457-9. PubMed ID: 2526619
    [Abstract] [Full Text] [Related]

  • 20. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI.
    Vopr Onkol; 1989 Jul 30; 35(7):771-8. PubMed ID: 2528239
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.